The combination of resveratrol and quercetin enhances the individual effects of these molecules on triacylglycerol metabolism in white adipose tissue

European Journal of Nutrition

Volumn 55, Issue 1, 2016, Pages 341-348

  Arias, Noemí ^a,b   Macarulla, M Teresa ^a,b   Aguirre, Leixuri ^a,b   Milton, Iñaki ^a   Portillo, María P ^a,b  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b Instituto de Salud Carlos III   (Spain)

Author keywords

Obesity; Quercetin; Rat; Resveratrol; White adipose tissue

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; FATTY ACID SYNTHASE; HEPARIN RELEASABLE LIPOPROTEIN LIPASE; HORMONE SENSITIVE LIPASE; LIPOPROTEIN LIPASE; QUERCETIN; RESVERATROL; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; CHOLESTEROL ESTERASE; FATTY ACID; GLUCOSE BLOOD LEVEL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; EPIDIDYMIS FAT; FOOD INTAKE; LIPID METABOLISM; LIPID STORAGE; LIPOGENESIS; MALE; MESENTERIC FAT; NONHUMAN; PERIRENAL FAT; PROTEIN EXPRESSION; RAT; SUBCUTANEOUS FAT; WESTERN BLOTTING; WHITE ADIPOSE TISSUE; ANIMAL; BLOOD; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; METABOLISM; ORGAN SIZE; PH; WISTAR RAT;

ACETYL-COA CARBOXYLASE; ADIPOSE TISSUE, WHITE; ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DRUG SYNERGISM; FATTY ACID SYNTHASES; FATTY ACIDS, NONESTERIFIED; HYDROGEN-ION CONCENTRATION; LIPID METABOLISM; LIPOPROTEIN LIPASE; MALE; ORGAN SIZE; QUERCETIN; RATS; RATS, WISTAR; STEROL ESTERASE; STILBENES; TRIGLYCERIDES;

EID: 84957428842     PISSN: 14366207     EISSN: 14366215     Source Type: Journal    
DOI: 10.1007/s00394-015-0854-9     Document Type: Article

References (51)

1. Kelly T, Yang W, Chen CS, Reynolds K, He J (2008) Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond) 32:1431–1437
2. van Strien T, Koenders PG (2012) How do life style factors relate to general health and overweight? Appetite 58:265–270
3. van Vliet-Ostaptchouk JV, Snieder H, Lagou V (2012) Gene–lifestyle interactions in obesity. Curr Nutr Rep 1:184–196
4. Szkudelska K, Szkudelski T (2010) Resveratrol, obesity and diabetes. Eur J Pharmacol 635:1–8
5. Aguirre L, Fernández-Quintela A, Arias N, Portillo MP (2014) Resveratrol: anti-obesity mechanisms of action. Molecules 19:18632–18655
6. Dal-Pan A, Blanc S, Aujard F (2010) Resveratrol suppresses body mass gain in a seasonal non-human primate model of obesity. BMC Physiol 10:11
7. Jimenez-Gomez Y, Mattison JA, Pearson KJ et al (2013) Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet. Cell Metab 18:533–545
8. Panchal SK, Poudyal H, Brown L (2012) Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats. J Nutr 142:1026–1032
9. Jung CH, Cho I, Ahn J, Jeon TI, Ha TY (2013) Quercetin reduces high-fat diet-induced fat accumulation in the liver by regulating lipid metabolism genes. Phytother Res 27:139–143
10. Yoshino J, Conte C, Fontana L et al (2012) Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab 16:658–664
11. Crandall JP, Oram V, Trandafirescu G et al (2012) Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci 67:1307–1312
12. Poulsen MM, Vestergaard PF, Clasen BF et al (2013) High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebo-controlled clinical trial of substrate metabolism, insulin sensitivity, and body composition. Diabetes 62:1186–1195
13. Chachay VS, Macdonald GA, Martin JH et al (2014) Resveratrol does not benefit patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 12(2092–2103):e2096
14. Cho SJ, Jung UJ, Choi MS (2012) Differential effects of low-dose resveratrol on adiposity and hepatic steatosis in diet-induced obese mice. Br J Nutr 108:2166–2175
15. Gómez-Zorita S, Fernández-Quintela A, Macarulla MT et al (2012) Resveratrol attenuates steatosis in obese Zucker rats by decreasing fatty acid availability and reducing oxidative stress. Br J Nutr 107:202–210
16. Timmers S, Konings E, Bilet L et al (2011) Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14:612–622
17. Yang JY, Della-Fera MA, Rayalam S et al (2008) Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci 82:1032–1039
18. Rayalam S, Della-Fera MA, Yang JY, Park HJ, Ambati S, Baile CA (2007) Resveratrol potentiates genistein’s antiadipogenic and proapoptotic effects in 3T3-L1 adipocytes. J Nutr 137:2668–2673
19. Park HJ, Yang JY, Ambati S et al (2008) Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes. J Med Food 11:773–783
20. Herranz-López M, Fernández-Arroyo S, Pérez-Sanchez A et al (2012) Synergism of plant-derived polyphenols in adipogenesis: perspectives and implications. Phytomedicine 19:253–261
21. Langcake P, Pryce RJ (1976) The production of resveratrol by Vitis vinifera and other members of the Vitaceae as a response to infection or injury. Physiol Plant Pathol 9:77–86
22. Somerset SM, Johannot L (2008) Dietary flavonoid sources in Australian adults. Nutr Cancer 60:442–449
23. Macarulla MT, Alberdi G, Gómez S et al (2009) Effects of different doses of resveratrol on body fat and serum parameters in rats fed a hypercaloric diet. J Physiol Biochem 65:369–376
24. Del Prado M, Hernandez-Montes H, Villalpando S (1994) Characterization of a fluorometric method for lipoprotein lipase. Arch Med Res 25:331–335
25. Miranda J, Churruca I, Fernández-Quintela A et al (2009) Weak effect of trans-10, cis-12-conjugated linoleic acid on body fat accumulation in adult hamsters. Br J Nutr 102:1583–1589
26. Alberdi G, Rodríguez VM, Miranda J et al (2011) Changes in white adipose tissue metabolism induced by resveratrol in rats. Nutr Metab (Lond) 8:29
27. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
28. Carpéné C, Gomez-Zorita S, Gupta R et al (2014) Combination of low dose of the anti-adipogenic agents resveratrol and phenelzine in drinking water is not sufficient to prevent obesity in very-high-fat diet-fed mice. Eur J Nutr 53:1625–1635
29. Arias N, Macarulla MT, Aguirre L et al (2011) The combination of resveratrol and conjugated linoleic acid is not useful in preventing obesity. J Physiol Biochem 67:471–477
30. Arias N, Miranda J, Macarulla MT et al (2014) The combination of resveratrol and conjugated linoleic acid attenuates the individual effects of these molecules on triacylglycerol metabolism in adipose tissue. Eur J Nutr 53:575–582
31. Lagouge M, Argmann C, Gerhart-Hines Z et al (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127:1109–1122
32. Rivera L, Morón R, Sánchez M, Zarzuelo A, Galisteo M (2008) Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring) 16:2081–2087
33. Shang J, Chen LL, Xiao FX, Sun H, Ding HC, Xiao H (2008) Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase. Acta Pharmacol Sin 29:698–706
34. Kim S, Jin Y, Choi Y, Park T (2011) Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochem Pharmacol 81:1343–1351
35. Kobori M, Masumoto S, Akimoto Y, Oike H (2011) Chronic dietary intake of quercetin alleviates hepatic fat accumulation associated with consumption of a Western-style diet in C57/BL6J mice. Mol Nutr Food Res 55:530–540
36. Arias N, Macarulla MT, Aguirre L, Martínez-Castaño MG, Portillo MP (2014) Quercetin can reduce insulin resistance without decreasing adipose tissue and skeletal muscle fat accumulation. Genes Nutr 9:361
37. Reagan-Shaw S, Nihal M, Ahmad N (2008) Dose translation from animal to human studies revisited. FASEB J 22:659–661
38. Timmers S, Auwerx J, Schrauwen P (2012) The journey of resveratrol from yeast to human. Aging (Albany NY) 4:146–158
39. de Ligt M, Timmers S, Schrauwen P (2014) Resveratrol and obesity: Can resveratrol relieve metabolic disturbances? Biochim Biophys Acta (in press)
40. National Institutes of Health (NIH) in USA. ClinicalTrials.gov
41. Rayalam S, Della-Fera MA, Ambati S, Boyan B, Baile CA (2007) Enhanced effects of guggulsterone plus 1,25(OH)2D3 on 3T3-L1 adipocytes. Biochem Biophys Res Commun 364:450–456
42. Panchal SK, Brown L (2011) Rodent models for metabolic syndrome research. J Biomed Biotechnol 2011:351982
43. Babacanoglu C, Yildirim N, Sadi G, Pektas MB, Akar F (2013) Resveratrol prevents high-fructose corn syrup-induced vascular insulin resistance and dysfunction in rats. Food Chem Toxicol 60:160–167
44. Vang O, Ahmad N, Baile CA et al (2011) What is new for an old molecule? Systematic review and recommendations on the use of resveratrol. PLoS ONE 6:e19881
45. Wang S, Moustaid-Moussa N, Chen L et al (2014) Novel insights of dietary polyphenols and obesity. J Nutr Biochem 25:1–18
46. Lane MD, Moss J, Polakis SE (1974) Acetyl coenzyme A carboxylase. Curr Top Cell Regul 8:139–195
47. Miyoshi H, Perfield JW, Obin MS, Greenberg AS (2008) Adipose triglyceride lipase regulates basal lipolysis and lipid droplet size in adipocytes. J Cell Biochem 105:1430–1436
48. Watt M, Steinberg G (2008) Regulation and function of triacylglycerol lipases in cellular metabolism. Biochem J 414:313–325
49. Haemmerle G, Lass A, Zimmermann R et al (2006) Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 312:734–737
50. Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS (2007) Regulation of lipolysis in adipocytes. Annu Rev Nutr 27:79–101
51. Zimmermann R, Strauss JG, Haemmerle G et al (2004) Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase. Science 306:1383–1386